Loading...

ADC Therapeutics SA (NYSE:ADCT)

7.89 USD +1.01 USD ( +14.68% )
Watchlist Manager
ADC Therapeutics SA
NYSE:ADCT
Watchlist

Relative Value

The Relative Value of one ADCT stock under the Base Case scenario is 15.32 USD. Compared to the current market price of 7.89 USD, ADC Therapeutics SA is Undervalued by 49%.

Relative valuation is one of two methods of placing a monetary value on a company; the other is Discounted Cash Flow valuation method. We use a combination of these two methods to calculate the Intrinsic Value of stock as accurately as possible.

ADCT Relative Value
Base Case
15.32 USD
Undervaluation 49%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Multiples Across Competitors

ADCT Competitors Multiples
ADC Therapeutics SA Competitors

Country Company Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
ADC Therapeutics SA
NYSE:ADCT
606M USD 7.5 N/A N/A N/A
US
Abbvie Inc
NYSE:ABBV
269B USD 4.7 21.6 11.4 16.1
US
Amgen Inc
NASDAQ:AMGN
131B USD 5 22.9 20 20
AU
CSL Ltd
ASX:CSL
128B AUD 8.4 38.3 24.7 29.4
US
Gilead Sciences Inc
NASDAQ:GILD
79.2B USD 2.9 17.5 7.2 7.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
74.8B USD 9.4 30.5 21.2 22.2

See Also

Similar Stocks